Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AbbVie Extends Reach Of Regenxbio’s Wet AMD Program
Deal May Indicate Renewed Pharma Appetite For Gene Therapy
Sep 13 2021
•
By
Alaric DeArment
Regenxbio stands to benefit from AbbVie's presence in eye care • Source: Shutterstock
More from Deals
More from Business